Biocon Limited has received approval from the South African Health Products Regulatory Authority (SAHPRA) for its vertically integrated, complex drug product Tacrolimus capsule 0.5mg, 1mg and 5mg strengths, in South Africa. This is the Company's first approval in this Country.
HYDERABAD, April 18 (Reuters) - Indian drugmaker Biocon (BION.NS), opens new tab, looking to grab a piece of the exploding weight-loss drug market as early as possible, is developing its own version of Novo Nordisk's (NOVOb.CO), opens new tab wildly popular Wegovy and is prepared to conduct a clinical trial next year if needed, the CEO told Reuters.
Biotechnology firm Biocon on Wednesday said it has tied up with Brazil-based Biomm SA for the commercialisation of its diabetes drug in the Latin American nation. Under the terms of the agreement, Biocon will undertake the development, manufacturing and supply of Semaglutide (gOzempic), and Biomm will be responsible for obtaining regulatory approval and commercialization in the Brazilian market.
Biocon Ltd. is pivoting to anti-obesity therapies as patents for the blockbuster medications start to expire, unleashing a wave of generic supply for the market that’s expected to touch $100 billion by 2030.
Biocon Limited, an innovation-led global biopharmaceuticals company, has announced that it has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), UK, for its complex formulation Liraglutide (6mg/ml solution for injection in pre-filled pen), which was filed through its European partner, Zentiva.
Biocon to sell branded formulations business to Eris Lifesciences for $150 mln
Novo Nordisk tackles harm from Ozempic fakes with global authorities
Biocon gets over Rs 3 crore penalty over GST related issues
India's Biocon posts profit on biosimilar boost, divestment gains; CFO resigns
Biocon CFO Indranil Sen resigns